{"disease":{"id":"esophageal-cancer","name":"Esophageal Cancer","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":46},"drugs":{"marketed":[{"drug_id":"ipilimumab","indication_name":"Unresectable advanced or recurrent esophageal cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yervoy","generic_name":"ipilimumab","company_name":"Bristol-Myers Squibb","drug_phase":"discontinued","molecular_target":"Cytotoxic T-lymphocyte protein 4","drug_class":"CTLA-4-directed Blocking Antibody","quality_score":0,"revenue":"2900","mechanism":"Yervoy blocks a protein called CTLA-4, which normally helps to turn off the immune system, allowing it to attack cancer cells."},{"drug_id":"tislelizumab","indication_name":"Esophageal Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tevimbra","generic_name":"TISLELIZUMAB","company_name":"Beigene","drug_phase":"marketed","molecular_target":"Pd-1","drug_class":"Programmed Death Receptor-1 Blocking Antibody [EPC]","quality_score":10,"revenue":"900","mechanism":"Tevimbra blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells."},{"drug_id":"capecitabine","indication_name":"Treatment of unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeloda","generic_name":"capecitabine","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":67,"revenue":null,"mechanism":"Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells."},{"drug_id":"yervoy","indication_name":"Unresectable advanced or recurrent esophageal cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Yervoy","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Cytotoxic T-lymphocyte protein 4","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06632886","title":"AI-Assisted Non-Contrast CT for Multi-Cancer Screening","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Guo ShiWei","has_results":false},{"nct_id":"NCT01077817","title":"Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)","phase":"","overall_status":"COMPLETED","enrollment_count":684815,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT00450788","title":"Esophageal Cancer in Northeastern Iran","phase":"","overall_status":"COMPLETED","enrollment_count":50045,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07022886","title":"INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":47000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT00342654","title":"Nutrition Intervention Trials in Linxian Follow-up Study","phase":"","overall_status":"COMPLETED","enrollment_count":32902,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05540119","title":"Swedish Oesophago-Gastric Study","phase":"","overall_status":"UNKNOWN","enrollment_count":25000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04609813","title":"Esophageal cAncer Screening Trial","phase":"","overall_status":"COMPLETED","enrollment_count":14597,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04958720","title":"Spanish Registry of Esophagogastric Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Fundación Sociedad Española de Oncologia Médica","has_results":false},{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT00341276","title":"Esophageal Cancer Genetics Studies","phase":"","overall_status":"COMPLETED","enrollment_count":7705,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07203690","title":"Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT07260734","title":"AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06440018","title":"INSPIRE: a Multi-Cancer Early Detection Study","phase":"","overall_status":"RECRUITING","enrollment_count":5350,"lead_sponsor_name":"Singlera Genomics Inc.","has_results":false},{"nct_id":"NCT03662204","title":"Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":5133,"lead_sponsor_name":"Exact Sciences Corporation","has_results":false},{"nct_id":"NCT07104214","title":"Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT03415815","title":"An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":3673,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT05460403","title":"Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection","phase":"","overall_status":"UNKNOWN","enrollment_count":3591,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03461341","title":"European iNvestigation of SUrveillance After Resection for Esophageal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"St. James's Hospital, Ireland","has_results":false},{"nct_id":"NCT06713421","title":"Effect of Premedication With Pronase on Mucosal Cleanliness During EGD","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04825834","title":"DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)","phase":"","overall_status":"COMPLETED","enrollment_count":2992,"lead_sponsor_name":"Delfi Diagnostics Inc.","has_results":false},{"nct_id":"NCT07022652","title":"Influence of Hospital Volume on Mortality and Length of Hospital Stay After Oesophageal Cancer Resection in Switzerland","phase":"","overall_status":"COMPLETED","enrollment_count":2880,"lead_sponsor_name":"Cantonal Hospital of St. Gallen","has_results":false},{"nct_id":"NCT00357682","title":"A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2557,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT06790355","title":"ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2527,"lead_sponsor_name":"Shanghai Weihe Medical Laboratory Co., Ltd.","has_results":false},{"nct_id":"NCT04214119","title":"EsophaCap for the Detection of Early Esophageal Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05177393","title":"Treatment Outcomes of Esophageal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2476,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05431621","title":"Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers","phase":"","overall_status":"COMPLETED","enrollment_count":2430,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06346080","title":"Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment","phase":"NA","overall_status":"RECRUITING","enrollment_count":2200,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT07431281","title":"Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2130,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07312526","title":"Shanghai Clinical Cohort - Esophageal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2116,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT02872116","title":"Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2031,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04821843","title":"Neoadjuvant Treatment Modalities in Esophageal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05334069","title":"Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT00359645","title":"Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1993,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT03428074","title":"A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1862,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07165210","title":"Incidence of 106TBL Lymph Node Metastasis","phase":"","overall_status":"RECRUITING","enrollment_count":1852,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05030870","title":"Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05604664","title":"Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc","phase":"","overall_status":"COMPLETED","enrollment_count":1727,"lead_sponsor_name":"Yongtao Han","has_results":false},{"nct_id":"NCT06314516","title":"Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":1717,"lead_sponsor_name":"Benaroya Research Institute","has_results":false},{"nct_id":"NCT02538562","title":"Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":1695,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05617352","title":"The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":1659,"lead_sponsor_name":"Yongtao Han","has_results":false},{"nct_id":"NCT05570487","title":"RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY","phase":"","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"Yongtao Han","has_results":false},{"nct_id":"NCT04314401","title":"National Cancer Institute \"Cancer Moonshot Biobank\"","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03829098","title":"TreatmENT of AnastomotiC Leakage After Esophagectomy","phase":"","overall_status":"COMPLETED","enrollment_count":1509,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT07354295","title":"Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Shu Peng","has_results":false},{"nct_id":"NCT05697198","title":"PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine","phase":"","overall_status":"COMPLETED","enrollment_count":1429,"lead_sponsor_name":"Labcorp Corporation of America Holdings, Inc","has_results":false},{"nct_id":"NCT04152499","title":"Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1410,"lead_sponsor_name":"Klus Pharma Inc.","has_results":false},{"nct_id":"NCT00242723","title":"Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining","phase":"","overall_status":"RECRUITING","enrollment_count":1310,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05405530","title":"Nasal Mask Kit in Gastrointestinal Endoscopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":1204,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06081647","title":"The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure","phase":"NA","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05105945","title":"Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1164,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}